News

Le XAV19 de XENOTHERA, un traitement prometteur pour les cas graves de Coronavirus

[Communiqué ] Nantes , le 19 mars 2020 XENOTHERA pense détenir aujourd’hui...

More

XENOTHERA presents at Toulouse ONCOWEEK 2020

At ONCOWEEK 2020 that will take place in Toulouse on Feb. 3-5,...

More

The first patient has been injected 2 weeks ago

[ Communiqué ] Nantes, December 12th, 2019 XENOTHERA is pleased to give...

More

XENOTHERA receives approval for first in man Kidney Transplant Clinical Trial

Nantes, September 11th, 2019 – XENOTHERA announces it has received  Czech Republic regulatory...

More

XENOTHERA presents at ESOT 2019

    XENOTHERA will participate at ESOT 2019 that will take place...

More

Xenothera Announces Publication in European Journal of Clinical Investigation on Immunological Mechanisms Underlining Use of LIS1

Kidney graft recipients receiving anti-lymphocyte globulins of animal origin undergo unwanted immune...

More

XENOTHERA to raise Series A

XENOTHERA has started to gather investors for a Series A round of...

More

XENOTHERA sponsors the realization of a fresco for the hospital by transplanted patients

Nantes, november 2017 The fresco, more than 8 meters long, has been...

More

XENOTHERA nominated for the Ernst&Young Entrepreneur Award

Nantes, September 2017 We have been selected for the 2017 entrepreneur awards...

More

Press Release: Start-up XENOTHERA closes a new capital increase above 2 million euros

June 10th, 2016 XENOTHERA, a young biotech who develops an innovative immunosuppressant,...

More

XENOTHERA moved to the Medicine Faculty of Nantes

September 1st, 2015 The Medicine Faculty of Nantes is welcoming the start-up...

More

XENOTHERA at Melbourne 2015 IXA

July 24th, 2015 Several partners of XENOTHERA will be present at the...

More

XENOTHERA at Biopharm America™ 2015

July 23th, 2015 XENOTHERA will participate in the Biopharm America that will...

More